Back to Journals » ImmunoTargets and Therapy
![](https://www.dovepress.com/cr_data/cache/journal_image/138/cope/thumb_100_1000_100.jpg)
ImmunoTargets and Therapy
ISSN: 2253-1556
![](https://www.dovepress.com/cr_data/cache/journal_image/138/thumb_215_215_100.jpg)
Editor-in-Chief: Professor Michael R Shurin
ImmunoTargets and Therapy is an international journal that aims to present and publish basic and clinical research on the aspects of immunology in health and disease. ImmunoTargets and Therapy is primarily focused on the immunological basis of disease and explores the evidence behind new and existing immunotherapies in terms of improving outcomes and, importantly, will seek to define their usage in terms of ultimate uptake and acceptance by the patient and health care professional.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Articles:
- View all (178)
- Volume 13, 2024 (23)
- Volume 12, 2023 (14)
- Volume 11, 2022 (6)
- Volume 10, 2021 (30)
- Volume 9, 2020 (27)
- Volume 8, 2019 (5)
- Volume 7, 2018 (10)
- Volume 6, 2017 (8)
- Volume 5, 2016 (8)
- Volume 4, 2015 (17)
- Volume 3, 2014 (14)
- Volume 2, 2013 (13)
- Volume 1, 2012 (3)
Latest articles:
- 5 records -
![Video](assets/img/article_icons/video.png)
Deciphering Natural Killer Cell Cytotoxicity Against Medulloblastoma in vitro and in vivo: Implications for Immunotherapy
![](assets/img/youtube_social_icon_dark.png)
![](http://img.youtube.com/vi/g6H8yg1fq1g/1.jpg)
Gauthier M, Pierson J, Moulin D, Mouginot M, Bourguignon V, Rhalloussi W, Vincourt JB, Dumas D, Bensoussan D, Chastagner P, Boura C, Decot V
ImmunoTargets and Therapy 2024, 13:319-333
Published Date: 26 June 2024
Survival Benefit of Synchronous Lenvatinib Combined PD-1 Inhibitors for Advanced Hepatocellular Carcinoma Beyond Oligometastasis
Xu K, Xiang C, Yu Z, Li J, Liu C
ImmunoTargets and Therapy 2024, 13:305-317
Published Date: 17 June 2024
Advances in the Understanding of the Correlation Between Neuroinflammation and Microglia in Alzheimer’s Disease
Yan H, Wang W, Cui T, Shao Y, Li M, Fang L, Feng L
ImmunoTargets and Therapy 2024, 13:287-304
Published Date: 12 June 2024
Mendelian Randomization Analysis of Circulating Cytokines and Risk of Autoimmune Neuroinflammatory Diseases
Tao SS, Cao F, Zhang RD, Xu SZ, Li XX, Tang J, Yang XK, Pan HF
ImmunoTargets and Therapy 2024, 13:273-286
Published Date: 10 June 2024
Targeted siRNA Therapy for Psoriasis: Translating Preclinical Potential into Clinical Treatments
Zhao F, Zhao J, Wei K, Jiang P, Shi Y, Chang C, Zheng Y, Shan Y, Li Y, He B, Zhou M, Liu J, Li L, Guo S, He D
ImmunoTargets and Therapy 2024, 13:259-271
Published Date: 16 May 2024